• Medical_Professionals
• Medical_students
• Nurses

Rapidly evolving technologies are transforming the way reproductive genetic diagnostics and screening are performed, but the differences, limitations, and benefits of these new technologies remain unclear to some. Cambridge Healthtech Institute’s Inaugural Reproductive Genetic Diagnostics conference aims to examine the latest technologies, including next-generation sequencing (NGS) and quantitative PCR, and their benefits and applications in carrier screening, preimplantation diagnostics, and product of conception (POC) testing.

As these technologies develop and become widespread, we must understand their capabilities, where each technology is best applied, and be sure that they have been analytically and clinically validated. Furthermore, as the technology outpaces practices, we must take a critical eye to the ethical implications of the applications of these technologies, including the regions of the genome that should be sequenced and the types and amount of sequence variation that is necessary for diagnosis. Join this event with your colleagues to meet with clinicians, researchers, developers, and key thought leaders and to examine these topics.

Preliminary Agenda

ADVANCES IN NGS AND OTHER TECHNOLOGIES

Keynote Presentation: Current and Expanding Invitations for Preimplantation Genetic Diagnosis (PGD)

Joe Leigh Simpson, MD, President for Research and Global Programs, March of Dimes Foundation

Next-Generation Sequencing: Its Role in Reproductive Medicine

Brynn Levy, Professor of Pathology & Cell Biology, CUMC; Director, Clinical Cytogenetics Laboratory, Co-Director, Division of Personalized Genomic Medicine, College of Physicians and Surgeons, Columbia University Medical Center, and the New York Presbyterian Hospital

Live Birth of Two Healthy Babies with Monogenic Diseases and Chromosome Abnormality Simultaneously Avoided by MALBAC-based Combined PGD and PGS

Xiaoliang Sunney Xie, Ph.D., Mallinckrodt Professor of Chemistry and Chemical Biology, Department of Chemistry and Chemical Biology, Harvard University

CCS without WGA

Nathan Treff, Director, Molecular Biology Research, Reproductive Medicine Associates of New Jersey, Associate Professor, Department of Obstetrics, Gynecology, and Reproductive Sciences, Rutgers-Robert Wood Johnson Medical School, Adjunct Faculty Member, Department of Genetics, Rutgers-The State University of New Jersey

Concurrent PGD for Single Gene Disorders and Aneuploidy on a Single Trophectoderm Biopsy

Rebekah S. Zimmerman, Ph.D., FACMG, Director, Clinical Genetics, Foundation for Embryonic Competence

GoodStart GeneticsAnalytical Validation of a Novel NGS-Based Preimplantation Genetic Screening Technology

Mark Umbarger, Ph.D., Director, Research and Development, Good Start Genetics

CLINICAL APPLICATIONS FOR ADVANCED TESTING TECHNOLOGIES

Expanded Carrier Screening for Monogenic Disorders

Peter Benn, Professor, Department of Genetics and Genome Sciences, University of Connecticut Health Center

Oocyte Mitochondrial Function and Testing: Implications for Assisted Reproduction

Emre Seli, MD, Yale School of Medicine

Numerical Chromosomal Abnormalities after PGS and D&C

Tanmoy Mukherjee, M.D., Assistant Clinical Professor, Obstetrics, Gynecology and Reproductive Science, Mount Sinai Hospital

Silicon BiosystemsRecovery and Analysis of Single (Fetal) Cells: DEPArray Based Strategy to Examine CPM and POC

Farideh Bischoff, Ph.D., Executive Director, Scientific Affairs, Silicon Biosystems, Inc. 

EMBRYO PREPARATION, ASSESSMENT, AND TREATMENT

Guidelines and Standards for Embryo Preparation: Embryo Culture, Growth and Biopsy Guidelines for Successful Genetic Diagnosis

Michael A. Lee, MS, TS, ELD (ABB), Director, Laboratories, Fertility Solutions

Current Status of Time-Lapse Imaging for Embryo Assessment and Selection in Clinical IVF

Catherine Racowsky, Professor, Department of Obstetrics, Gynecology & Reproductive Biology, Harvard Medical School; Director, IVF Laboratory, Brigham & Women’s Hospital

The Curious Case of Fresh versus Frozen Transfer

Denny Sakkas, Ph.D., Scientific Director, Boston IVF

Why Does IVF Fail? Finding a Single Euploid Embryo is Harder than You Think

Jamie Grifo, M.D., Ph.D., Program Director, New York University Fertility Center; Professor, New York University Langone Medical Center

USD

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

Omni Parker House Hotel  

56-98, School Street Boston United States of America

Submission Info

Cambridge Healthtech Institute encourages attendees to gain further exposure by presenting their work in the poster sessions. To secure a poster board and inclusion in the conference materials, your abstract must be submitted, approved and your registration paid in full by October 9, 2015. 

Register online, or by phone, fax or mail.  Please indicate that you would like to present a poster.  Once your registration has been fully processed, we will send an email with a unique link and instructions for submitting your abstract using our online abstract submission tool.  Please see below for more information. 

Reasons you should present your research poster at this conference:  

Your poster will be seen by our international delegation, representing leaders from top pharmaceutical, biotech, academic and government institutions

Receive $50 off your registration 

Your poster abstract will be published in our conference materials 

CHI offers comprehensive packages that can be customized to your budget and objectives. Sponsorship allows you to achieve your goals before, during, and long after the event. Packages may include presentations, exhibit space and branding, as well as the use of delegate lists. Signing on early will maximize your exposure to qualified decision-makers and drive traffic to your website in the coming months. 

Podium Presentations — Available within Main Agenda! 

Showcase your solutions to a guaranteed, targeted audience through a 15- or 30-minute presentation during a specific conference program, breakfast, lunch, or separate from the main agenda within a pre-conference workshop. Package includes exhibit space, on-site branding, and access to cooperative marketing efforts by CHI. For the luncheon option, lunches are delivered to attendees who are already seated in the main session room. Presentations will sell out quickly, so sign on early to secure your talk! 

Invitation-Only VIP Dinner/Hospitality Suite 

Select specific delegates from the pre-registration list to attend a private function at an upscale restaurant or a reception at the hotel. From extending the invitations, to venue suggestions, CHI will deliver your prospects and help you make the most of this invaluable opportunity. 

Focus Group 

CHI will gladly provide you the opportunity of running a focus group on-site. This exclusive gathering can be useful to conduct market research, collect feedback on a new product idea, and collect marketing intelligence from industry experts on a specific topic. 

User Group Meeting/Custom Event 

Co-locate your user group meeting or custom event. CHI will help market the event, manage logistical operations, develop the agenda, and more. CHI can handle the entirety of the meeting or select aspects.  

Exhibit 

Exhibitors will enjoy facilitated networking opportunities with qualified delegates, making it the perfect platform to launch a new product, collect feedback, and generate new leads. Exhibit space sells out quickly, so reserve yours today! 

Additional branding and promotional opportunities are available, including: 

• Conference Tote Bags

• Literature Distribution (Tote Bag Insert or Chair Drop)

• Badge Lanyards

• Program Guide Advertisement

• Padfolios and More...  

For more information, please contact: 

Ilana Quigley

Business Development Manager

Cambridge Healthtech Institute

781-972-5457 | iquigley@healthtech.com

CHI Contact Information

250 First Avenue

Suite 300

Needham, MA 02494

Phone: 781-972-5400

Toll-Free: 888-999-6288

Fax: 781-972-5425